Valrubicin: an alternative to radical cystectomy for carcinoma in situ of the bladder.
Treatment options for patients who fail BCG therapy are limited. While cystectomy may be curative, not all patients can withstand the medical and/or psychologic stresses associated with surgery or resection. Valrubicin represents a safe and effective second-line intravesical therapy.
Randall
S
S
Urology Health Center, New Port Richey, FL, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001500:BCG Vaccine; D002278:Carcinoma in Situ / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing / Q000601:surgery; D015653:Cystectomy; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006801:Humans; D009367:Neoplasm Staging; D009730:Nursing Assessment; D001749:Urinary Bladder Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000451:nursing / Q000601:surgery
D000970:Antineoplastic Agents; D001500:BCG Vaccine; C016163:valrubicin; D004317:Doxorubicin